SYNthesis Research is a small molecule drug discovery company focussing on both early-stage deal flow and strategic longer-term clinical development programs.
Headquartered in Melbourne Australia, SYNthesis Research maximises the benefits of the favourable Australian R&D environment to progress its Drug Discovery & Development portfolio. It does this by leveraging its exceptional Innovation Network - An integrated, federated Australian-Chinese R&D network optimised to provide non-dilutive R&D services to the company’s programs, at costs up-to 60% lower than other global locations.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 63 Exhibition St, Melbourne,victoria 3000,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- thepharm.bio
- Keywords
- to the company’s programs.
- HQ
- Melbourne, Victoria
Synthesis Research Questions
Synthesis Research's website is thepharm.bio
Synthesis Research's LinkedIn profile is https://au.linkedin.com/company/synthesis-research
Synthesis Research has
5 employees.
View email and phone details for 5
employees at Synthesis Research.
Synthesis Research's industry is
Biotechnology Research
Synthesis Research's top competitors are
Synthesis Med Chem,
Anaxis Pharma,
Vaxxas,
Zucero Therapeutics Ltd,
Catalyst Therapeutics,
Qubigen,
Aculeus Therapeutics,
Bcal Diagnostics,
Synthesis Bioventures,
Oncology One Pty Ltd.
Synthesis Research's categories are Biotechnology Research
Synthesis Research's founding year is 2012
